Salubris Biotherapeutics Announces $32 Million Financing To Advance Novel Complex Biologics For Cardiovascular, Oncology, And Neurodegenerative Diseases
Amount Raised
$32 Million
Round Type
Funding Round
GaithersburgBiotechnologyHealth CareDescription
Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced it received $32 million in financing from China-based Shenzhen Salubris Pharmaceuticals Co., Ltd. The investment, which was completed in the fourth quarter of 2021, will be used to advance the current pipeline, including continuation of an ongoing Phase 1b clinical trial and initiation of two additional Phase 1b clinical trials in 2022, and to further expand the pipeline through R&D.
Quick answer
Salubris Biotherapeutics raised $32 Million in a Funding Round round, dated March 7, 2022. Salubris Biotherapeutics is based in Gaithersburg, Maryland, United States.
- How much did Salubris Biotherapeutics raise?
- Salubris Biotherapeutics raised $32 Million in a Funding Round round on March 7, 2022.
- What does Salubris Biotherapeutics do?
- SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com).
- Where is Salubris Biotherapeutics based and how big is it?
- Salubris Biotherapeutics is based in Gaithersburg, Maryland, United States.
- Who are the decision-makers at Salubris Biotherapeutics?
- Fundz holds 1 contact at Salubris Biotherapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Salubris Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- ENDRA Life Sciences raised $8.7M (Post-IPO Equity) on April 21, 2022.
- OXOS Medical raised $1.8M (Seed) on April 21, 2022.
- Unlearn raised $50M on April 19, 2022.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Modifi Bio raised $10M on April 19, 2022.
- Alto Neuroscience raised $172K on April 19, 2022.
Who to call at Salubris Biotherapeutics, and when
A new round usually means Salubris Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Salubris Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Salubris Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Salubris Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Salubris Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Salubris Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.